Market Tracker

07/24 6:05pm ET

Incyte Corp (NASDAQ:INCY)

47.95
Data as of Jul 24
 -1.03 / -2.10%
Today’s Change
22.51
Today|||52-Week Range
70.86
-5.29%
Year-to-Date

Today’s Trading

Previous close48.98
Today’s open48.48
Day’s range47.66 - 48.74
Volume1,156,774
Average volume (3 months)1,559,270
Market cap$8.2B
Dividend yield--
Data as of 4:00pm ET, 07/24/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+11.33%
Earnings growth (next 5 years)+83.94%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SLXPSalix Pharmaceutical...-0.09-0.07%
HSPHospira Inc+1.16+2.29%
PCYCPharmacyclics Inc+0.58+0.56%
RDYDr.Reddy's Laborator...-0.81-1.79%
Data as of 4:03pm ET, 07/24/2014

Financials

Next reporting dateJuly 31, 2014
EPS forecast (this quarter)$0.10
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David C. Hastings
Corporate headquarters
Wilmington, Delaware

Forecasts